EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic
First Claim
Patent Images
1. An analgesic, anesthetic and antipruritic formulation comprising:
- 0.01 to 13 wt % alkyl esters;
20 to 70 wt. % Emu oil;
10 to 33 wt % benzyl alcohol;
10 to 33 wt % benzoin;
0.2 to 2 wt % allantoin 0.25 to 1.25 wt % methylparaben; and
0.01 to 0.30 wt % propylparaben.
3 Assignments
0 Petitions
Accused Products
Abstract
An analgesic, anesthetic and antipruritic formulation is provided containing 0.01 to 13 wt % alkyl esters; and 20 to 70 wt % Emu oil; 10 to 33 wt % benzyl alcohol; 10 to 33 wt % benzoin; 0.2 to 2 wt % allantoin; 0.25 to 1.25 wt % methylparaben and 0.01 to 0.30 wt % propylparaben. The formulation may be formulated as a spray or transdermal formula. The formulation may be used for treatment of chronic cutaneous ulcers and burn wounds.
-
Citations
11 Claims
-
1. An analgesic, anesthetic and antipruritic formulation comprising:
-
0.01 to 13 wt % alkyl esters;
20 to 70 wt. % Emu oil;
10 to 33 wt % benzyl alcohol;
10 to 33 wt % benzoin;
0.2 to 2 wt % allantoin 0.25 to 1.25 wt % methylparaben; and
0.01 to 0.30 wt % propylparaben. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10)
-
-
11. An analgesic, anesthetic and antipruritic spray-on transdermal formula comprising:
-
0.01 to 13 wt % alkyl esters;
20 to 70 wt % refined and sterilized Emu oil;
10 to 33 wt % benzyl alcohol;
10 to 33 wt % benzoin;
0.2 to 2 wt % allantoin;
0.25 to 1.25 wt % methylparaben;
0.01 to 0.30 wt % propylparaben; and
sufficient and effective amounts of environmentally safe propellants.
-
Specification